I bought into CPRX at 0.80 per share. Now the easy money has already been made and I am slowly trimming my position. Check out CYNAF for the next big winner. Analysts are just starting to take notice. They just received a million dollar grant from the Michael J Fox foundation for developing an oral drug to replace the currently approved self injection drug. Its the same compound so approval should be easy. Patent protection until 2031. Look what the analyst from Zack's research had to say:
"I think it could be a $500M or more opportunity. Parkinson's is an enormous indication, and almost all Parkinson's patients experience this on/off phenomenon. This is a very clean, low-risk story, and I love the way Cynapsus has pulled this off, being the first to patent this delivery. If this were a U.S. stock, it would be four or five times the price it is now, but because it's in Canada, no one knows about it."